Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ximena A Levander

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Addiction Science & Clinical Practice|December 13, 2021
Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysisXimena A Levander, Kim A Hoffman, John W McIlveen, et al.
Journal of Addiction Medicine|December 26, 2021
Low Dose Initiation of Buprenorphine: A Narrative Review and Practical ApproachShawn M Cohen, Melissa B Weimer, Ximena A Levander, et al.
Drug and Alcohol Dependence Reports|August 7, 2024
Association of economic and racial segregation with restricted buprenorphine dispensing in U.S. community pharmaciesKyle J Moon, Sabriya L Linton, Neda J Kazerouni, et al.
Addiction (Abingdon, England)|March 2, 2023
A gender-based secondary analysis of the ADAPT-2 combination naltrexone and bupropion treatment for methamphetamine use disorder trialXimena A Levander, Thomas Carmody, Ryan R Cook, et al.
Drug Metabolism Reviews|September 6, 2007
Serum iron increases with acute induction of hepatic heme oxygenase-1 in miceVolker Mostert, Akihiro Nakayama, Lori M Austin, et al.
Journal of Addiction Medicine|August 10, 2021
Low-Threshold Buprenorphine via Community Partnerships and Telemedicine-Case Reports of Expanding Access to Addiction Treatment During COVID-19Ximena A Levander, Haven Wheelock, Justine Pope, et al.
Journal of General Internal Medicine|November 16, 2023
The Role of Human-Centered Design in Healthcare Innovation: a Digital Health Equity Case StudyXimena A Levander, Hans VanDerSchaaf, Vanessa Guerrero Barragán, et al.
Journal of Substance Abuse Treatment|May 19, 2022
Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysisKim A Hoffman, Canyon Foot, Ximena A Levander, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|December 16, 2022
Evaluation of treatment access and scope of a multistate hepatitis C virus Extension for Community Healthcare Outcomes telehealth service in the US Indian Health System, 2017-2021Ashley N Wirth, Nicholas A Cushman, Brigg A Reilley, et al.
Contemporary Clinical Trials Communications|December 7, 2022
Recruitment challenges for a prospective telehealth cohort studyKellie Pertl, Ritwika Petluri, Katharina Wiest, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Addiction Science & Clinical Practice|December 13, 2021
Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysisXimena A Levander, Kim A Hoffman, John W McIlveen, et al.
Journal of Addiction Medicine|December 26, 2021
Low Dose Initiation of Buprenorphine: A Narrative Review and Practical ApproachShawn M Cohen, Melissa B Weimer, Ximena A Levander, et al.
Drug and Alcohol Dependence Reports|August 7, 2024
Association of economic and racial segregation with restricted buprenorphine dispensing in U.S. community pharmaciesKyle J Moon, Sabriya L Linton, Neda J Kazerouni, et al.
Addiction (Abingdon, England)|March 2, 2023
A gender-based secondary analysis of the ADAPT-2 combination naltrexone and bupropion treatment for methamphetamine use disorder trialXimena A Levander, Thomas Carmody, Ryan R Cook, et al.
Drug Metabolism Reviews|September 6, 2007
Serum iron increases with acute induction of hepatic heme oxygenase-1 in miceVolker Mostert, Akihiro Nakayama, Lori M Austin, et al.
Journal of Addiction Medicine|August 10, 2021
Low-Threshold Buprenorphine via Community Partnerships and Telemedicine-Case Reports of Expanding Access to Addiction Treatment During COVID-19Ximena A Levander, Haven Wheelock, Justine Pope, et al.
Journal of General Internal Medicine|November 16, 2023
The Role of Human-Centered Design in Healthcare Innovation: a Digital Health Equity Case StudyXimena A Levander, Hans VanDerSchaaf, Vanessa Guerrero Barragán, et al.
Journal of Substance Abuse Treatment|May 19, 2022
Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysisKim A Hoffman, Canyon Foot, Ximena A Levander, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|December 16, 2022
Evaluation of treatment access and scope of a multistate hepatitis C virus Extension for Community Healthcare Outcomes telehealth service in the US Indian Health System, 2017-2021Ashley N Wirth, Nicholas A Cushman, Brigg A Reilley, et al.
Contemporary Clinical Trials Communications|December 7, 2022
Recruitment challenges for a prospective telehealth cohort studyKellie Pertl, Ritwika Petluri, Katharina Wiest, et al.
Pageof 4